Cargando…

Obesity associates with vasomotor symptoms in postmenopause but with physical symptoms in perimenopause: a cross-sectional study

BACKGROUND: Middle-aged women experience various menopausal symptoms during the menopause. These symptoms can affect their quality of life and health. Several epidemiological studies reported that obesity associates with menopausal symptoms. The aim of this cross-sectional study was to examine the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koo, Seul, Ahn, Younjhin, Lim, Joong-Yeon, Cho, Juhee, Park, Hyun-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721621/ https://www.ncbi.nlm.nih.gov/pubmed/29216853 http://dx.doi.org/10.1186/s12905-017-0487-7

Ejemplares similares

Association between physical activity and menopausal symptoms in perimenopausal women
por: Kim, Min-Ju, et al.
Publicado: (2014)

Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause
por: Jaeger, Marianna de B., et al.
Publicado: (2020)

Metabolically healthy and unhealthy obesity and risk of vasomotor symptoms in premenopausal women: cross‐sectional and cohort studies
por: Namgoung, Sunju, et al.
Publicado: (2022)

Perimenopause vasomotor symptoms, coronary atherosclerosis and risk of myocardial infarction during menopause: the cardiologist’s perspective
por: Savonitto, Stefano, et al.
Publicado: (2018)

Sympathetic Skin Response and Vasomotor Symptoms in Postmenopausal Osteoporotic Women
por: Ashraf, Alireza, et al.
Publicado: (2015)

Relationship between vasomotor symptoms and metabolic syndrome in postmenopausal women
por: Sayan, Sena, et al.
Publicado: (2018)

Vasomotor symptoms and the homeostatic model assessment of insulin-resistance in Korean postmenopausal women
por: Kwon, Dae Hui, et al.
Publicado: (2016)

The Impact of Soy Isoflavone Supplementation on the Menopausal Symptoms in Perimenopausal and Postmenopausal Women
por: Khapre, Shrutika, et al.
Publicado: (2022)

Vasomotor and physical menopausal symptoms are associated with sleep quality
por: Kim, Min-Ju, et al.
Publicado: (2018)

The Role of Lifestyle in Developing and Maintaining Vasomotor Symptoms: A Cross-Sectional Study among Iranian Postmenopausal Women
por: Hashemzadeh, Mozhgan, et al.
Publicado: (2019)

Alcohol Consumption Patterns and Risk of Early-Onset Vasomotor Symptoms in Premenopausal Women
por: Kwon, Ria, et al.
Publicado: (2022)

Vasomotor Symptoms: More Than Temporary Menopausal Symptoms
por: Ryu, Ki-Jin, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease and Risk of Early-Onset Vasomotor Symptoms in Lean and Overweight Premenopausal Women
por: Cho, Yoosun, et al.
Publicado: (2022)

Perimenopausal and Postmenopausal Health
por: Cheung, Angela M, et al.
Publicado: (2004)

Effectiveness of a modified version of the applied relaxation technique in treatment of perimenopausal and postmenopausal symptoms
por: Saensak, Suprawita, et al.
Publicado: (2013)

Role of the pharmacist in the management of postmenopausal breast cancer treatment with vasomotor symptoms: A case report
por: Undeberg, Megan R., et al.
Publicado: (2023)

Ideal Cardiovascular Health Metrics and Risk of Incident Early-Onset Vasomotor Symptoms Among Premenopausal Women
por: Choi, Hye Rin, et al.
Publicado: (2022)

Vasomotor and other menopause symptoms and the prevalence of ideal cardiovascular health metrics among premenopausal stage women
por: Choi, Hye Rin, et al.
Publicado: (2023)

Postmenopausal women's experiences of a resistance training intervention against vasomotor symptoms: a qualitative study
por: Berin, Emilia, et al.
Publicado: (2022)

High low-density lipoprotein cholesterol level is associated with an increased risk of incident early-onset vasomotor symptoms
por: Choi, Hye Rin, et al.
Publicado: (2022)

Critical appraisal of paroxetine for the treatment of vasomotor symptoms
por: Carroll, Dana G, et al.
Publicado: (2015)

Hops for Menopausal Vasomotor Symptoms: Mechanisms of Action
por: Abdi, Fatemeh, et al.
Publicado: (2016)

Keeping an Eye on Perimenopausal and Postmenopausal Endometriosis
por: Matalliotakis, Michail, et al.
Publicado: (2019)

Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms
por: Simon, James A., et al.
Publicado: (2019)

SAT-237 Combined Bioidentical Estradiol and Progesterone Capsules Improved Quality of Sleep in Postmenopausal Women with Vasomotor Symptoms
por: Santoro, Nanette, et al.
Publicado: (2019)

Low anti-Müllerian hormone levels are associated with an increased risk of incident early-onset vasomotor symptoms among premenopausal women
por: NamGoung, SunJu, et al.
Publicado: (2022)

Vasomotor symptoms, sleep problems, and depressive symptoms in community‐dwelling Japanese women
por: Tomida, Makiko, et al.
Publicado: (2021)

Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
por: Umland, Elena M, et al.
Publicado: (2012)

Comparative study of gabapentin and isoflavone in menopausal vasomotor symptoms
por: Singhal, Savita Rani, et al.
Publicado: (2016)

Psychosomatic and vasomotor symptom changes during transition to menopause
por: Augoulea, Areti, et al.
Publicado: (2019)

MON-387 Pheochromocytoma Masquerading as Vasomotor Menopausal Symptoms
por: Xhikola, Majlinda, et al.
Publicado: (2019)

The Cause of Vasomotor Symptoms: Resonance Phenomena in the Vascular Bed
por: Uohashi, Keiko
Publicado: (2022)

Premenstrual Disorders, Timing of Menopause, and Severity of Vasomotor Symptoms
por: Yang, Yihui, et al.
Publicado: (2023)

Receptive Functions at Childbearing Age, Perimenopause and Postmenopause
por: Rosic, Semso, et al.
Publicado: (2014)

Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden
por: Nappi, Rossella E., et al.
Publicado: (2021)

Neurokinin 3 receptor antagonists for menopausal vasomotor symptoms, an appraisal
por: Gompel, Anne, et al.
Publicado: (2023)

Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
por: Pinkerton, JoAnn V, et al.
Publicado: (2023)

Treatment Strategies for Reducing the Burden of Menopause-Associated Vasomotor Symptoms
por: Umland, Elena M.
Publicado: (2008)

P02.139. A comparative study of Chinese medicine and hormone therapy in the treatment of menopausal symptoms in perimenopausal and postmenopausal women
por: Azizi, H, et al.
Publicado: (2012)

Adding Agnus Castus and Magnolia to Soy Isoflavones Relieves Sleep Disturbances Besides Postmenopausal Vasomotor Symptoms-Long Term Safety and Effectiveness
por: De Franciscis, Pasquale, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_50ju6776pgr0hecidpq5pn9f20